Fortress Biotech Inc FBIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/14/24 EDT
1.74UNCH (UNCH)
Volume
97,509
52 week range
1.24 - 11.25
Loading...
  • Open1.79
  • Day High1.79
  • Day Low1.72
  • Prev Close1.74
  • 52 Week High11.25
  • 52 Week High Date05/16/23
  • 52 Week Low1.24
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap33.468M
  • Shares Out19.23M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.66
  • YTD % Change-42.19

KEY STATS

  • Open1.79
  • Day High1.79
  • Day Low1.72
  • Prev Close1.74
  • 52 Week High11.25
  • 52 Week High Date05/16/23
  • 52 Week Low1.24
  • 52 Week Low Date11/10/23
  • Market Cap33.468M
  • Shares Out19.23M
  • 10 Day Average Volume0.13M
  • Dividend-
  • Dividend Yield-
  • Beta1.66
  • YTD % Change-42.19

RATIOS/PROFITABILITY

  • EPS (TTM)-53.18
  • P/E (TTM)-0.03
  • Fwd P/E (NTM)-0.30
  • EBITDA (TTM)-133.025M
  • ROE (TTM)-213.73%
  • Revenue (TTM)84.513M
  • Gross Margin (TTM)68.45%
  • Net Margin (TTM)-182.40%
  • Debt To Equity (MRQ)283.25%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Fortress Biotech Inc

 

Profile

MORE
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has seven marketed prescription pharmaceutical products and over 25 programs in development at the Company, at its majority-owned and majority-controlled partners and subsidiaries and at partners and subsidiaries it founded and in which it holds significant minority ownership positions. Such product candidates span six market areas, including oncology, rare diseases...
Lindsay Rosenwald M.D.
Executive Chairman of the Board, President, Chief Executive Officer
David Jin
Chief Financial Officer and Head of Corporate Development
Address
1111 KANE CONCOURSE, SUITE 301
Bay Harbor Islands, FL
33154
United States

Top Peers

SYMBOLLASTCHG%CHG
HLTH
Cue Health Inc
0.112UNCHUNCH
PSNL
Personalis Inc
1.43UNCHUNCH
RDHL
Redhill Biopharma Ltd
0.46UNCHUNCH
CDTX
Cidara Therapeutics Inc
12.71UNCHUNCH
DTIL
Precision BioSciences Inc
12.09UNCHUNCH